HDAC6 inhibitors sensitize resistant t(11;14) multiple myeloma cells to a combination of bortezomib and BH3 mimetics

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)784-790
Number of pages7
JournalHaematologica
Volume110
Issue number3
DOIs
Publication statusPublished - 1 Mar 2025
Externally publishedYes

Cite this